Avecho Biotechnology Limited의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Avecho Biotechnology Limited은 수익성이 있나요?
Avecho Biotechnology Limited에 부채가 있나요?
Avecho Biotechnology Limited의 발행 주식은 몇 주인가요?
주요 통계
이전 종가
$0.0045
시가
$0.0045
일일 범위
$0.003 - $0.0045
52주 범위
$0.0014 - $0.0174
거래량
300.0K
평균 거래량
0
EPS(TTM)
0.00
배당수익률
--
시가총액
$13.2M
AVECHO BIOTECHNOLOGY LTD란 무엇인가요?
Avecho Biotechnology Ltd. engages in the development and commercialization of human and animal products through its proprietary drug delivery system. The company is headquartered in Melbourne, Victoria. The firm develops and commercializes human and animal health products using its proprietary drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from Vitamin E using proprietary and patented processes. The firm's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The firm's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol, Veterinary Applications, among others. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.